Skip to content

US · ASBPW

Aspire Biopharma Holdings, Inc.

Programmatic access: valuation JSON for this ticker · catalog · agent briefing · agent card. Paid lookups: HTTP 402 then Payment-Authorization, or Authorization: Bearer ic_live_….

Sector
Healthcare · Biotechnology
Headquarters
Humacao, NY 10013

Price · as of 2026-09-01

$0.02

Market cap 193.23K

Price history

The price history chart is shown only to users with a Pro subscription.

InvestorsCraft valuation

Fair value (AI, DCF / IC, Graham) for Aspire Biopharma Holdings, Inc. (ASBPW) is available to Pro members and via the machine API.

  • AI valuation — available
  • Intrinsic / IC value — available
  • Upside vs price — available

Valuation history

Annual price overlaid with each model's fair value. Y-axis is log scale.

The valuation history chart is shown only to users with a Pro subscription.

Historic valuation ratios

Pick a category, then toggle metrics to compare.

Historic valuation ratios are shown only to users with a Pro subscription.

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. is a biotechnology company specializing in advanced diagnostic solutions and molecular testing. The company focuses on developing high-precision assays for disease detection, leveraging cutting-edge research in genetics and biochemistry to support healthcare and life sciences industries.

CEO
Kraig T. Higginson
Employees
2
Beta
-1.04

Peer comparison

Same-industry comparables, ranked by market cap.

The peer comparison table is shown only to users with a Pro subscription.

Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice.